Related references
Note: Only part of the references are listed.Paraoxonase 1 (PON1) reduces macrophage inflammatory responses
Saar Aharoni et al.
ATHEROSCLEROSIS (2013)
Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease Role of High-Density Lipoprotein-Proteome Remodeling
Meliana Riwanto et al.
CIRCULATION (2013)
Cholesterol-Induced Membrane Microvesicles As Novel Carriers of Damage-Associated Molecular Patterns Mechanisms of Formation, Action, and Detoxification
Ming-Lin Liu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
A molecular view on signal transduction by the apoptosome
Thomas F. Reubold et al.
CELLULAR SIGNALLING (2012)
Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation
David Hine et al.
IUBMB LIFE (2012)
The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins
Soumaya Loued et al.
LIFE SCIENCES (2012)
Regulation of Endothelial Function by Mitochondrial Reactive Oxygen Species
Michael E. Widlansky et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release
Marie Koren-Gluzer et al.
ATHEROSCLEROSIS (2011)
Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity
Mira Rosenblat et al.
BIOFACTORS (2011)
Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques
Judit Marsillach et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
Christian Besler et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Redox imbalance of red blood cells impacts T lymphocyte homeostasis: implication in carotid atherosclerosis
Elisabetta Profumo et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Circulating endothelial cells are elevated in patients with type 1 diabetes mellitus
Ebru Asicioglu et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
Judit Marsillach et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease
Judit Marsillach et al.
BMC GASTROENTEROLOGY (2009)
The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment
Judit Marsillach et al.
CLINICAL BIOCHEMISTRY (2009)
The paraoxonases: role in human diseases and methodological difficulties in measurement
Jordi Camps et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2009)
Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties
Orit Rozenberg et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy
N Joza et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications:: Endothelial dysfunction, as a common underlying theme
P Pacher et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase
O Khersonsky et al.
BIOCHEMISTRY (2005)
Oxidative stress and vascular disease
NR Madamanchi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells
B Mackness et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development
M Aviram et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Share Paper
